Fig. 2
From: Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis

Cumulative incidence of thrombotic events in the first five years of TAM treatment
From: Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis

Cumulative incidence of thrombotic events in the first five years of TAM treatment